Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2025 | ePROMs in SACT pre-treatment assessment for sustainable breast cancer care

Gemma Jones, The Christie NHS Foundation Trust, Manchester, UK, explores the use of electronic patient-reported outcome measures (ePROMs) to streamline pre-assessments for systemic anti-cancer therapy (SACT) in breast cancer. ePROMs can reduce the need for telephone and in-person reviews, shorten call duration, and free substantial staff time, supporting more sustainable oncology care. This interview took place at the European Society for Medical Oncology (ESMO) 2025 Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

So we’ve started using the ePROMs for a way of pre-assessing our patients who are having SAC treatment with us. We are a very large unit so to have any innovation like this that’ll help to make our work streams more efficient and also involve the patients more in their care can only be a beneficial thing. We’ve also found that in doing so it saved a lot of nurse time in what would be telephone consultations that we can now involve the patient in giving us that information and hopefully lead to less interactions with the patient and the clinical teams and just make that streamlined and more efficient...

So we’ve started using the ePROMs for a way of pre-assessing our patients who are having SAC treatment with us. We are a very large unit so to have any innovation like this that’ll help to make our work streams more efficient and also involve the patients more in their care can only be a beneficial thing. We’ve also found that in doing so it saved a lot of nurse time in what would be telephone consultations that we can now involve the patient in giving us that information and hopefully lead to less interactions with the patient and the clinical teams and just make that streamlined and more efficient.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...